20 results
8-K
EX-99.1
LIANY
LianBio
13 Feb 24
LianBio Announces Completion of Strategic Review
7:04am
on a mission to bring transformative medicines to historically underserved patients in China and other Asian markets. For more information, please
8-K
EX-99.1
LIANY
LianBio
20 Dec 23
LianBio Announces Departure of Chief Financial Officer
8:05am
of the LianBio Board of Directors.
About LianBio
LianBio is a cross-border biotechnology company on a mission to bring transformative medicines
8-K
EX-99.1
LIANY
LianBio
19 Dec 23
LianBio Announces Departure of Chief Executive Officer
4:26pm
strategic review in the first quarter of 2024.
About LianBio
LianBio is a cross-border biotechnology company on a mission to bring transformative
8-K
EX-99.1
LIANY
LianBio
6 Dec 23
Regulation FD Disclosure
4:23pm
.
About LianBio
LianBio is a cross-border biotechnology company on a mission to bring transformative medicines to historically underserved patients
8-K
EX-99.1
LIANY
LianBio
1 Dec 23
Other Events
4:16pm
course.
About LianBio
LianBio is a cross-border biotechnology company on a mission to bring transformative medicines to historically underserved
8-K
EX-99.1
mh6fti
13 Nov 23
LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:17pm
8-K
EX-99.1
cyow6czzlsevihd4
30 Oct 23
LianBio Announces Topline Results from Phase 3 LIBRA Trial of
4:16pm
8-K
EX-99.1
sptlqvgh
14 Aug 23
LianBio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:11pm
8-K
EX-99.1
mklf02dwims08 5jhf
11 May 23
LianBio Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:23pm
8-K
EX-99.1
b195olfnl xss25cs
1 May 23
Regulation FD Disclosure
7:28am
8-K
EX-99.1
0ena4z vpt3xq3mgki
26 Apr 23
LianBio Announces Positive Topline Results from Phase 3 EXPLORER-CN Trial Evaluating Mavacamten in Chinese Patients
8:07am
8-K
EX-99.1
wkl6cwnvokl5
21 Apr 23
Other Events
4:13pm
8-K
EX-99.1
bs9hpwv5el4meirswmwv
19 Dec 22
Entry into a Material Definitive Agreement
7:04am
8-K
EX-99.1
xkkd9gzrhts273 1w
13 Dec 22
LianBio Announces President and Chief Strategy Officer Departure
5:03pm
8-K
EX-99.1
j5xsh7ri5kni
10 Nov 22
LianBio Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:16pm
8-K
EX-99.1
69i3i l7ca
11 Aug 22
LianBio Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:30pm
8-K
EX-99.1
ggqo1p xk
12 May 22
LianBio Reports First Quarter 2022 Financial Results and Provides Corporate Update
9:15am
8-K
EX-99.1
bdl9po72flv91 fdl
8 Apr 22
LianBio Appoints Wei Wei Chen to Board of Directors
4:10pm
8-K
EX-99.1
ohmmadk5hk3 m4g
30 Mar 22
LianBio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:55pm
8-K
EX-99.1
h9m z4krawa8
9 Dec 21
LianBio Provides Corporate Update and Reports Third Quarter 2021 Financial Results
4:59pm
- Prev
- 1
- Next